Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Aclaris Therapeutics, Inc. shareholders
As of Jun 30, 2026, 143 institutions reported holding Aclaris Therapeutics, Inc., 82.3% of its shares. Largest: Ra Capital Management, L.P., BML Capital Management, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aclaris Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 12.7M | 8.6% | +5.92M | Aug 14, 2026 |
| BML Capital Management, LLC | 12M | 8.1% | −2.27M | Aug 7, 2026 |
| BlackRock | 10M | 6.8% | +2.63M | Aug 7, 2026 |
| Deep Track Capital, LP | 9.35M | 6.3% | no change | Aug 14, 2026 |
| Vanguard | 8.34M | 5.7% | +797K | Aug 13, 2026 |
| Vivo Capital, LLC | 6.69M | 4.5% | +27,971 | Aug 14, 2026 |
| Frazier Life Sciences Management, L.P. | 4.93M | 3.3% | no change | Aug 14, 2026 |
| Rock Springs Capital Management LP | 4.33M | 2.9% | −142K | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | 4.07M | 2.8% | +200K | Aug 14, 2026 |
| Decheng Capital LLC | 4.04M | 2.7% | no change | Aug 14, 2026 |